TNF and CINCA syndrome: Recently, TNF has been implicated in CINCA pathogenesis and successful treatment of two children with anti-TNF drug etanercept has shown clinical remission of cutaneous and neurologic symptoms as well as alleviation of systemic inflammation (Luo et al., 2020).